Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 180

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Systematic review: impact of non‐adherence to 5‐aminosalicylic acid products on the frequency and cost of ulcerative colitis flares

Open access
HIGGINS, P. D. R., RUBIN, D. T., KAULBACK, K., SCHOENFIELD, P. S., KANE, S. V. · 2009 · Alimentary Pharmacology & Therapeutics

Abstract

Summary: Background Ulcerative colitis (UC) can be maintained in remission with 5‐aminosalicylic acid (5‐ASA) medications, but frequent non‐adherence by patients who are feeling well has been associated with more frequent flares of colitis. Aim To perform a systematic review of the published literature and unpublished randomized clinical trials (RCTs) regarding the impact of non‐adherence with 5‐ASA medications on the incidence of UC flares and costs of care. Methods A search of MEDLINE, EMBASE and the Cochrane databases was performed. Prospective studies of UC maintenance with 5‐ASAs in adults were selected if they included data on adherence and disease flares. Studies using insurance claims data to estimate the impact of non‐adherence on cost of care were included. Data from unpublished RCTs were obtained from the FDA with a request under the Freedom of Information Act. Results The relative risk for flare in non‐adherent vs. adherent patients ranged from 3.65 to infinity. Data were obtained from six unpublished 5‐ASA RCTs, but none measured the impact of adherence on disease activity. The comorbidity‐adjusted annual costs of care in adherent patients were 12.5% less than in non‐adherent patients, despite increased medication expenditures. Conclusions A substantial proportion of UC flares and medical costs of UC are attributable to 5‐ASA non‐adherence. As non‐adherence to 5‐ASA medications is common, cost‐effective strategies to improve adherence are needed. The impact of adherence on disease activity should be measured in RCTs of all inflammatory bowel disease treatments.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2036.2008.03865.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 180

Metadata

Authors
HIGGINS, P. D. R., RUBIN, D. T., KAULBACK, K., SCHOENFIELD, P. S., & KANE, S. V.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2008-12-22
Volume
29
Issue
3
Pages
247-257
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2085950678
Cited by
180
References
3
FWCI
0.87
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Systematic review: impact of non‐adherence to 5‐aminosalicylic acid products on the frequency and cost of ulcerative colitis flares. https://app.cochat.ai/papers/10.1111/j.1365-2036.2008.03865.x
The paper
HIGGINS, P. D. R., RUBIN, D. T., KAULBACK, K., SCHOENFIELD, P. S., & KANE, S. V. (2009). Systematic review: impact of non‐adherence to 5‐aminosalicylic acid products on the frequency and cost of ulcerative colitis flares. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2008.03865.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.